Breast health and screening
This page is reference information compiled from the cited sources. It is not medical advice. For any decision about health, diagnosis or care, consult a qualified professional.
What it is
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. A number of screening tests have been employed, including clinical and self breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging. A clinical or self breast exam involves feeling the breast for lumps or other abnormalities. Mammography is a type of radiography used on the breasts, typically used for medical screening of apparently healthy women. Magnetic resonance imaging is used to guide treatment, but is not an established screening method for healthy women.
Key facts
Medical evidence does not support the use of clinical or self breast exams in women with a typical risk for breast cancer. Universal screening with mammography is controversial as it may not reduce all-cause mortality and may cause harms through unnecessary treatments and medical procedures. The United States Preventive Services Task Force recommends screening mammography in women at normal risk for breast cancer, every other year between the ages of 40 and 74. Earlier, more aggressive, and more frequent screening is recommended for women at particularly high risk of developing breast cancer, such as those with a confirmed BRCA mutation. Screening mammography in older women increases medical treatment and saves a small number of lives, but usually has no effect on the outcome of any breast cancer that it detects.
When to seek professional help
Any lumps, thickenings, hardened knots, or any other breast changes should be brought to the attention of a healthcare provider. It is also important to look for changes in color or shape, nipple discharge, dimpling, and swelling. Abnormal findings on screening are further investigated by surgically removing a piece of the suspicious lumps to examine them under the microscope. If suspicious signs are identified in a mammogram image, then the woman is usually recalled for a second mammogram or a biopsy of the breast. Women who have mammograms may end up with increased surgeries, chemotherapy, radiotherapy and other potentially procedures resulting from the over-detection of harmless lumps.
Source: Breast cancer screening (CC BY-SA 4.0 (Wikipedia)), retrieved 2026-09-30.
Latest reporting

Mental Health Review Warns of Failing System and Overdiagnosis Risk
A government-commissioned review finds England's mental health and autism assessment system is failing young people.

Australian Abortion Pill Access Widens After Policy Change
A 2023 rule change allowing more health workers to prescribe the abortion pill MS-2 Step led to a nearly 50% increase in pharmacy stocking by...

NHS mental health trusts referred to CQC over Oxevision
Ten NHS mental health trusts have been referred to the Care Quality Commission after an internal review found failures in patient consent procedures...

Giredestrant-Everolimus Doubles Survival in ESR1-Mutated Breast Cancer
The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with...

FDA Grants Priority Review For Elinzanetant Hot Flash Treatment
The FDA has granted priority review to elinzanetant for treating hot flashes in women undergoing endocrine therapy for HR+ breast cancer.

Enhertu drug approved for NHS use in England
About 1,000 women a year in England with incurable HER2-low breast cancer will get the life-extending drug Enhertu on the NHS following a price deal.